Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after ¹²⁵I Particle Therapy for Differentiated Thyroid Cancer

Table 3

Comparison of adverse reactions between the two groups (cases, %).

Time	Groups	Nausea	Radiation gastritis	Radiation parotitis	Neck discomfort
1 week after treatment	Low-dose group ()	6 (11.54%)	2 (3.85%)	3 (5.77%)	8 (15.38%)
	High-dose group ()	15 (28.85%)	9 (17.31%)	10 (19.23%)	17 (32.69%)
		4.833	4.981	4.308	4.265
		0.028	0.026	0.038	0.039
1 month after treatment	Low-dose group ()	2 (3.85%)	1 (1.92%)	2 (3.85%)	5 (9.62%)
	High-dose group ()	8 (15.38%)	2 (3.85%)	3 (5.77%)	8 (15.38%)
		3.983	0.343	0.210	0.791
		0.046	0.558	0.647	0.374
3 months after treatment	Low-dose group ()	1 (1.92%)	1 (1.92%)	0 (0.00%)	2 (3.85%)
	High-dose group ()	2 (3.85%)	3 (5.77%)	1 (1.92%)	3 (5.77%)
		0.343	1.040	1.010	0.210
		0.558	0.308	0.315	0.647